Sanofi delivers Q1 2015 Business EPS growth of 2.6% at CER and 12.8% on a reported basis
First quarter results 2015 were reviewed by management during a conference call. The presentation was followed by a Q&A session.
First quarter results 2015 were reviewed by management during a conference call. The presentation was followed by a Q&A session.
This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies.